Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
65 /100
HIGH RISK
Score updated Aug 28, 2026

LNAI — Lunai Bioworks Inc. Dilution Risk Tracker

Track LNAI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LNAI — Get alerts when the score changes →

As of August 28, 2026, Lunai Bioworks Inc. (LNAI) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Lunai Bioworks Inc. has a market capitalization of $13.96M, 36.27M shares outstanding, 28 institutional holders tracked. Stored dilution-related fields include 3.43M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
85
📊 Float Risk
100
⚠️ Warrant Exposure
30
🔄 Convertible Debt
15

Dilution Forecast

Watch
Minor dilution signals detected
model est. 25%
💰 Capital Raise model 35%
• Low cash runway: 4 months remaining
🔄 Reverse Split model est. 15%
• Only 4 months cash — financial pressure
📜 Warrant Exercise model 15%
• Warrant overhang: 9.4% of shares outstanding
🔔 Track LNAI — Get forecast alerts →

Market Data

Market Cap$13.96M
Shares Outstanding36.27M
Float3.35M
Cash$3.16M
Debt$204.1K
Short InterestN/A

Institutional Holdings

QoQ: ↓ 10.0% shares (2026Q1 vs prior)
28 institutional holders · 1.00M shares
#1 GEODE CAPITAL MANAGEMENT, LLC 182.2K shares
#2 BlackRock, Inc. 127.3K shares
#3 NINE MASTS CAPITAL Ltd 102.4K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest136.7K
Days to Cover5.1
% of Float4.1%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-31
xbrl XBRL WARRANT 2024-06-30
8-K/A 8K EVENT 2026-05-11
8-K 8K EVENT 2026-05-01
8-K 8K EVENT 2026-03-30
Full SEC filing analysis available with free account

Recent News

No recent news

Factual LNAI Dilution Snapshot

Lunai Bioworks Inc. (LNAI) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track LNAI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LNAI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for LNAI
LNAI FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.